Clare Mccormick-Baw, M.D., Ph.D.

Pathology

Education & Training

Fellowship - UT Southwestern Medical Center (2018-2019), Medical Microbiology
Residency - Baylor Scott & White Medical Center (2014-2018), Pathology
Medical School - LSU Health Sciences Center New Orleans (2009-2014)

Books & Publications

Publications
- Cutaneous Leishmania mexicana Infections in the United States: Defining Strains Through Endemic Human Pediatric Cases in Northern Texas.
  Nepal B, McCormick-Baw C, Patel K, Firmani S, Wetzel DM, medRxiv : the preprint server for health sciences 2024 Jan
- Limited Clinical Utility of Routine Mycobacterial Cultures for the Management of Diabetic Foot Infections.
  Castellino LM, McCormick-Baw C, Coye T, Crisologo PA, Hanna JJ, Lee F, Clark A, Fanning M, Killeen AL, Open forum infectious diseases 2023 Nov 10 11 ofad558
- Persistent CMV pneumonitis in HIV infection: a case report.
  Frederick AW, Kitchell E, McCormick-Baw C, Kukkar V, Jain MK, BMC infectious diseases 2023 Nov 23 1 842
- Limited Clinical Utility of Routine Mycobacterial Cultures for the Management of Diabetic Foot Infections
  Castellino LM, McCormick-Baw C, Coye T, Crisologo PA, Hanna JJ, Lee F, Clark A, Fanning M, Killeen AL Open Forum in Infectious Diseases 2023 11 10
- The Brief Case: Encephalitis in a West Texas Woman.
  McCormick-Baw C, Clark A, Knights S, Perl T, Cavuoti D, Journal of clinical microbiology 2022 Nov 60 11 e0227121
- Closing the Brief Case: Encephalitis in a West Texas Woman.
  McCormick-Baw C, Clark AE, Knights S, Perl T, Cavuoti D, Journal of clinical microbiology 2022 Nov 60 11 e0228621
- Saliva for use with a point of care assay for the rapid diagnosis of COVID-19.
  SoRelle JA, Mahimainathan L, McCormick-Baw C, Cavuoti D, Lee F, Thomas A, Sarode R, Clark AE, Muthukumar A, Clinica chimica acta; international journal of clinical chemistry 2020 Sep
- Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
  McCormick-Baw C, Morgan K, Gaffney D, Cazares Y, Jaworski K, Byrd A, Molberg K, Cavuoti D, Journal of clinical microbiology 2020 Jul 58 8
- Staphylococcus aureus infection of the rabbit cornea following topical administration.
  Tang A, Balzli CL, Caballero AR, McCormick CC, Taylor SD, O'Callaghan RJ, Current eye research 2012 Dec 37 12 1075-83
- Diverse virulence of Staphylococcus aureus strains for the conjunctiva.
  McCormick CC, Caballero AR, Balzli CL, Tang A, Weeks A, O'Callaghan RJ, Current eye research 2011 Jan 36 1 14-20
- The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
  Balzli CL, McCormick CC, Caballero AR, Tang A, O'Callaghan RJ, Advances in therapy 2010 Dec 27 12 933-40
- A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis.
  Balzli CL, Bartell J, Dajcs JJ, McCormick CC, Caballero AR, Stroman D, O'Callaghan RJ, Investigative ophthalmology & visual science 2010 Oct 51 10 5114-20
- Sustained anti-staphylococcal effect of lysostaphin in the rabbit aqueous humor.
  Balzli CL, McCormick CC, Caballero AR, O'Callaghan RJ, Current eye research 2010 Jun 35 6 480-6
- Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions.
  Tang A, Marquart ME, Fratkin JD, McCormick CC, Caballero AR, Gatlin HP, O'Callaghan RJ, Investigative ophthalmology & visual science 2009 Aug 50 8 3794-801
- Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus.
  McCormick CC, Caballero AR, Balzli CL, Tang A, O'Callaghan RJ, Investigative ophthalmology & visual science 2009 Jun 50 6 2848-54
- Development of a Streptococcus pneumoniae keratitis model in mice.
  Moore QC, McCormick CC, Norcross EW, Onwubiko C, Sanders ME, Fratkin J, McDaniel LS, O'Callaghan RJ, Marquart ME, Ophthalmic research 2009 42 3 141-6
- Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
  McCormick C, Caballero A, Tang A, Balzli C, Song J, O'Callaghan R, Current medical research and opinion 2008 Jun 24 6 1569-75
- Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
  Balzli CL, McCormick CC, Caballero AR, Huang B, Wigington L, Smith E, Tang A, O'Callaghan RJ, Journal of cataract and refractive surgery 2008 Feb 34 2 295-301
- Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
  O'Callaghan RJ, McCormick CC, Caballero AR, Marquart ME, Gatlin HP, Fratkin JD, Investigative ophthalmology & visual science 2007 Nov 48 11 5125-31
- Surfactant protein D in Pseudomonas aeruginosa keratitis.
  McCormick CC, Hobden JA, Balzli CL, Reed JM, Caballero AR, Denard BS, Tang A, O'Callaghan RJ, Ocular immunology and inflammation 2007 Sep-Oct 15 5 371-9
- Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.
  Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O'Callaghan RJ, Investigative ophthalmology & visual science 2007 Jun 48 6 2661-6
- The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.
  McCormick CC, Dajcs JJ, Reed JM, Marquart ME, O'Callaghan RJ, Current eye research 2006 Mar 31 3 225-30
- Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
  Reed JM, O'Callaghan RJ, Girgis DO, McCormick CC, Caballero AR, Marquart ME, Investigative ophthalmology & visual science 2005 Feb 46 2 604-8